Raising Lazarus: The Search For Solutions
- Date:
-
Tuesday, March 12, 2024
- Time:
- 7:30 - 8:30 p.m.
- Location:
Olin Theater
The James C. and S. Maynard Turk Pre-Law Program presents the Gentry Locke Lecture featuring journalist and bestselling author ("Factory Man," "Truevine") Beth Macy.
Olin Theater
Libba Cooper, Office of Community Programs - programs@roanoke.edu false MM/DD/YYYYJames C. and S. Maynard Turk Pre-Law Program presents the Gentry Locke Lecture featuring journalist and bestselling author ("Factory Man," "Truevine") Beth Macy.
Macey will discuss the unraveling of rural America, from the aftermath of globalization to the opioid crisis, the subject of her latest book "Dopesick."
Beth Macy is a Virginia-based journalist who writes about outsiders and underdogs. Raised poor in a small Ohio community, she is the award-winning author of three New York Times bestselling books examining rural communities left behind by corporate greed and political indifference. Her first book, "Factory Man," explored the aftermath of globalization and won a J. Anthony Lukas Prize. "Dopesick" was short-listed for the Carnegie Medal, won the L.A. Times Book Prize for Science and Technology, and was described as a “masterwork of narrative nonfiction” by The New York Times.
"Dopesick" was made into a Peabody- and Emmy Award-winning Hulu series; Macy was an executive producer and cowriter on the show. Her 2022 book, "Raising Lazarus: Hope, Justice, and the Future of America’s Overdose Crisis," was a follow-up that explored on-the-ground solutions to the nation’s drug epidemic.
A 2010 Nieman Fellow for Journalism at Harvard and a 2023 Guggenheim Fellow, Macy has also written for The New York Times, The Wall Street Journal, The Atlantic, and The Washington Post. Her next book, "Paper Girl," is a combination memoir and reported examination of the rural-urban divide told through the lenses of declining upward mobility, political polarization, and the decimation of local and regional news.
Beth Macy is represented exclusively by the BrightSight Group